Summit Therapeutics (SMMT) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/10/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO

6. COO
7. IRT
8. LAES
9. QCOM
10. CHWY

Price: $17.54 +1.50%

EPS Growth %: -115.4%

Today's EPS Names:
IMPP, RH, YB, More

Summit Therapeutics (NASDAQ: SMMT) reported Q2 EPS of (GBP0.28), in-line with the analyst estimate of (GBP0.28).

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!